Shire in good shape on verge of Takeda sale
Takeda-Shire deal: the strategy behind Japan's largest foreign acquisition - Pharmaceutical Technology
Takeda reaches $62B deal to buy Shire - Drug Delivery Business
Takeda and Shire finally agree takeover terms after months of negotiations – The New Economy
Reviewing The Takeda-Shire Merger (NASDAQ:SHPG) | Seeking Alpha
Takeda agrees to buy Shire in £46bn deal - BBC News
How Takeda's $62 Billion Shire Deal Reshapes Pharma World - Bloomberg
Japan's Takeda family brands Shire deal 'a disaster'
Takeda Pharmaceutical and Shire receive shareholders' approval for Takeda-Shire deal | AlphaStreet
Showdown over Shire looms as rebels fight Takeda takeover - The Boston Globe
Global Firms Play Big Role as Japan's Takeda Wins Battle for Shire in $62 Billion Deal
It's Official! Takeda Pharma to Buy Shire for $62.2 Billion | BioSpace
A combined Takeda Shire would be the ninth biggest pharma company in the world by sales - Verdict
Takeda's $60bn offer for Shire rejected as too low - Nikkei Asia
THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT AND INVESTORS SHOULD NOT MAKE ANY I
Takeda's record Shire deal could put it in global top 10 - Independent.ie
Takeda struggles to deliver returns from massive Shire deal - Nikkei Asia
Shire board recommends £46bn takeover by Japanese drugmaker Takeda | Shire | The Guardian
Takeda and Shire Agree Merger Terms | CHEManager
Japan's Takeda agrees $62 billion takeover of Shire
Analysts Question Takeda-Shire Deal, Speculate on Bidding War | BioSpace
Takeda chief takes £46bn gamble on Shire takeover | Financial Times
Takeda Pharmaceutical Agrees $62.4 Billion Takeover of Shire - TheStreet
Takeda seeks to divest $10bn of assets after £46bn Shire deal | Financial Times
